IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: Localization, partial characterization, and expression

Mammalian Genome

Volumn 18, Issue 1, 2007, Pages 53-63

  Marcos Carcavilla, Ane ^a   Calvo, Jorge H ^b   González, Carmen ^a   Moazami Goudarzi, Katayoun ^c   Laurent, Pascal ^c   Bertaud, Maud ^c   Hayes, Hélène ^c   Beattie, Anne E ^d   Serrano, Carmen ^e   Lyahyai, Jaber ^e   Martín Burriel, Inmaculada ^e   Alves, Estefânia ^a   Zaragoza, Pilar ^e   Badiola, Juan J ^f   Serrano, Magdalena ^a  

^a INIA   (Spain)

^b Instituto Agroalimentario de Aragón IA2   (Spain)

^c Institut National de la Recherche Agronomique   (France)

^d INVERMAY AGRICULTURAL CENTRE   (New Zealand)

^e UNIVERSIDAD DE ZARAGOZA   (Spain)

^f UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; GENE ISOLATION; GENE LOCATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 1RN GENE; LINKAGE ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCRAPIE; SHEEP;

CAPRA HIRCUS; OVIS; OVIS ARIES;

EID: 33846784858     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-006-0095-6     Document Type: Article

References (62)

1. Baker CA, Manuelidis L (2003) Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 100, 675-679
2. Bensi G, Mora M, Raugei G, Buonamassa DT, Rossini M, et al. (1990) An inducible enhancer controls the expression of the human interleukin 1 beta gene. Cell Growth Differ 1, 491-497
3. Betmouni S, Perry VH, Gordon JL (1996) Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74, 1-5
4. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, et al. (1994) Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37, 1380-1385
5. Blakemore AI, Watson PF, Weetman AP, Duff GW (1995) Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 80, 111-115
6. Breathnach R, Chambon P (1981) Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 50, 349-383
7. Brown AR, Webb J, Rebus S, Walker R, Williams A, et al. (2003) Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease. J Gen Virol 84, 2605-2611
8. Butcher C, Steinkasserer A, Tejura S, Lennard A (1994) Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J Immunol 153, 701-711
9. Campbell IL, Eddleston M, Kemper P, Oldstone MB, Hobbs MV (1994) Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol 68, 2383-2387
10. Carlson GA, Goodman PA, Lovett M, Taylor BA, Marshall ST, et al. (1988) Genetics and polymorphism of the mouse prion gene complex: control of scrapie incubation time. Mol Cell Biol 8, 5528-5540
11. Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, et al. (2001) Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 48: 461-467
12. Clarke MC, Haig DA (1971) Multiplication of scrapie agent in mouse spleen. Res Vet Sci 12, 195-197
13. Crawford AM, Dodds KG, Ede AJ, Pierson CA, Montgomery GW, et al. (1995) An autosomal genetic linkage map of the sheep genome. Genetics 140, 703-724
14. Cunningham C, Deacon R, Wells H, Boche D, Waters S, et al. (2003) Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 17, 2147-2155
15. Cunningham C, Wilcockson DC, Boche D, Perry VH (2005) Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease. J Virol 79, 5174-5184
16. Danis VA, Millington M, Hyland VJ, Grennan D (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99, 303-310
17. Diaz C, Vitezica ZG, Rupp R, Andreoletti O, Elsen JM (2005) Polygenic variation and transmission factors involved in the resistance/susceptibility to scrapie in a Romanov flock. J Gen Virol 86, 849-857
18. Dickinson AG (1975) Host-pathogen interactions in scrapie. Genetics 79 Suppl, 387-395
19. Dickinson AG, Fraser H, Meikle VM, Outram GW (1972) Competition between different scrapie agents in mice. Nat New Biol 237, 244-245
20. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398-402
21. Endres S, Cannon JG, Ghorbani R, Dempsey RA, Sisson SD, et al. (1989) In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 19, 2327-2333
22. Garcia-Crespo D, Juste R, Hurtado A (2005) Selection of ovine housekeeping genes for normalisation by real-time RT-PCR; analysis of PrP gene expression and genetic susceptibility to scrapie. BMC Vet Res 1, 3
23. Hayes H, Petit E, Dutrillaux B (1991) Comparison of RBG-banded karyotypes of cattle, sheep, and goats. Cytogenet Cell Genet 57, 51-55
24. Hunninghake GW, Monks BG, Geist LJ, Monick MM, Monroy MA, et al. (1992) The functional importance of a cap site-proximal region of the human prointerleukin 1 beta gene is defined by viral protein transactivation. Mol Cell Biol 12, 3439-3448
25. Jenkins J, Drong R, Shuck M, Bienkowski M, Slightom J, et al. (1997) Intracellular IL-1 receptor antagonist promoter: cell type-specific and inducible regulatory regions. J Immunol 158, 748-755
26. Keen RW, Woodford-Richens KL, Lanchbury JS, Spector TD (1998) Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone 23, 367-371
27. Kim JI, Ju WK, Choi JH, Choi E, Carp RI, et al. (1999) Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Brain Res Mol Brain Res 73, 17-27
28. Kominato Y, Galson D, Waterman W, Webb A, Auron P (1995) Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1. Mol Cell Biol 15, 59-68
29. Lander ES, Green P (1987) Construction of multilocus genetic linkage maps in humans. Proc Natl Acad Sci USA 848, 2363-2367
30. Licastro F, Veglia F, Chiappelli M, Grimaldi LM, Masliah E (2004) A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease. Neurobiol Aging 25, 1017-1022
31. Lloyd SE, Onwuazor ON, Beck JA, Mallinson G, Farrall M, et al. (2001) Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 98, 6279-6283
32. Lloyd SE, Uphill JB, Targonski PV, Fisher EM, Collinge J (2002) Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics 4, 77-81
33. Lyahyai J, Bolea R, Serrano C, Monleon E, Moreno C, et al. (2006) Correlation between Bax overexpression and prion deposition in medulla oblongata from natural scrapie without evidence of apoptosis. Acta Neuropathol 112:451-460
34. Maddox JF, Davies KP, Crawford AM, Hulme DJ, Vaiman D, et al. (2001) An enhanced linkage map of the sheep genome comprising more than 1000 loci. Genome Res 11, 1275-1289
35. Manolakou K, Beaton J, McConnell I, Farquar C, Manson J, et al. (2001) Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci USA 98, 7402-7407
36. McGeer PL, Yasojima K, McGeer EG (2002) Association of interleukin-1 beta polymorphisms with idiopathic Parkinson's disease. Neurosci Lett 326, 67-69
37. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215
38. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, et al. (1994) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180, 147-150
39. Moreno CR, Cosseddu GM, Andreoletti O, Schibler L, Roig A, et al. (2003a) [Identification of quantitative trait loci (QTL) modulating prion incubation period in sheep.] Proceedings of the International Workshop on Major Genes and QTL in Sheep and Goat, Toulouse, France, 8-11 December 2002, Communication No. 2-27
40. Moreno CR, Lantier F, Lantier I, Sarradin P, Elsen JM (2003b) Detection of new quantitative trait Loci for susceptibility to transmissible spongiform encephalopathies in mice. Genetics 165, 2085-2091
41. Mrak RE, Griffin WS (2001) Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 22, 903-908
42. Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie (1998) IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87, 309-313
43. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95, 13363-13383
44. Schultz J, Schwarz A, Neidhold S, Burwinkel M, Riemer C, et al. (2004) Role of interleukin-1 in prion disease-associated astrocyte activation. Am J Pathol 165, 671-678
45. Sciacca FL, Ferri C, Licastro F, Veglia F, Biunno I, et al. (2003) Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol Aging 24, 927-931
46. Shirakawa F, Saito K, Bonagura CA, Galson DL, Fenton MJ, et al. (1993) The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol 13, 1332-1344
47. Smith M Jr, Eidlen D, Brewer M, Eisenberg S, Arend W, et al. (1992) Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions. J Immunol 149, 2000-2007
48. Smith M Jr, Eidlen D, Arend W, Gutierrez-Hartmann A (1994) LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J Immunol 153, 3584-3593
49. Stephenson DA, Chiotti K, Ebeling C, Groth D, DeArmond SJ, et al. (2000) Quantitative trait loci affecting prion incubation time in mice. Genomics 69, 47-53
50. Tseng Y-H, Schuler LA (1998) Transcriptional regulation of interleukin-1beta gene by interleukin-1beta itself is mediated in part by Oct-1 in thymic stromal cells. J Biol Chem 273, 12633-12641
51. Tsukada J, Saito K, Waterman WR, Webb AC, Auron PE (1994) Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene. Mol Cell Biol 14, 7285-7297
52. Tsukada J, Waterman W, Koyama Y, Webb A, Auron P (1996) A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL 1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene. Mol Cell Biol 16, 2183-2194 [erratum: Mol Cell Biol 16, 3233]
53. Vaiman D, Billault A, Tabet-Aoul K, Schibler L, Vilette D, et al. (1999) Construction and characterization of a sheep BAC library of three genome equivalents. Mamm Genome 10, 585-587
54. Vamvakopoulos J, Green C, Metcalfe S (2002) Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 32, 2988-2996
55. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034
56. Vitkovic L, da Cunha A, Tyor WR (1994) Cytokine expression and pathogenesis in AIDS brain. Res Publ Assoc Res Nerv Ment Dis 72, 203-222
57. Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, et al. (2000) Cytokine signals propagate through the brain. Mol Psychiatry 5, 604-615
58. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, et al. (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51, 651-662
59. Williams AE, Lawson LJ, Perry VH, Fraser H (1994a) Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 20, 47-55
60. Williams AE, van Dam AM, Man AHWK, Berkenbosch F, Eikelenboom P, et al. (1994b) Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res 654, 200-206
61. Williams A, Van Dam AM, Ritchie D, Eikelenboom P, Fraser H (1997) Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res 754, 171-180
62. Xiang W, Windl O, Wunsch G, Dugas M, Kohlmann A, et al. (2004) Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol 78, 11051-11060